Drug Shortage Report for INDERAL-LA

Last updated on 2018-02-08 History
Report ID 36382
Drug Identification Number 02042274
Brand name INDERAL-LA
Common or Proper name INDERAL LA
Company Name PFIZER CANADA ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) PROPRANOLOL HYDROCHLORIDE
Strength(s) 160MG
Dosage form(s) CAPSULE (SUSTAINED-RELEASE)
Route of administration ORAL
Packaging size 1x100 CAPS
ATC code C07AA
ATC description BETA BLOCKING AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-01-15
Estimated end date
Actual end date 2018-02-07
Shortage status Resolved
Updated date 2018-02-08
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2018-02-08 French Compare
v3 2018-02-08 English Compare
v2 2018-01-17 French Compare
v1 2018-01-17 English Compare

Showing 1 to 4 of 4